Active Psoriatic arthritis

Also known as: Psoriatic arthritis aggravated / Psoriatic arthropathy aggravated / Psoriatic arthropathy NOS (disorder) / Psoriatic arthropathy / Arthropathy psoriatic / Psoriatic arthritis / Psoriasis with arthropathy (disorder) / Arthritis, Psoriatic / Psoriatic arthropathies / Arthropathic psoriasis / Arthropathic psoriasis, unspecified

DrugDrug NameDrug Description
DB05676ApremilastA non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis.
DB08904Certolizumab pegolA tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis.
DB06674GolimumabA TNF╬▒ inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
DB11569IxekizumabA monoclonal antibody used to treat moderate to severe plaque psoriasis.
DB14762RisankizumabAn interleukin-23 antagonist used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, and moderately to severely active Crohn's disease in adults.
DB09029SecukinumabAn immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.
DB15091UpadacitinibAn oral Janus kinase (JAK)1-selective inhibitor used in the treatment of moderate to severe rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, and severe atopic dermatitis, including in patients who did not respond well to other therapies.
DB05679UstekinumabA targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.
DrugDrug NamePhaseStatusCount
DB16650Deucravacitinib2Completed1
DB05679Ustekinumab2Completed1
DB08904Certolizumab pegol3Completed1
DB12917Bimekizumab4Not Yet Recruiting1